12 June 2020
Rapid planning is in hand to enable possible new vaccine trials research by Barts Health.
Recruits to the Oxford COVID-19 Vaccination trial include Dr David Collier, Clinical Director at the William Harvey Clinical Research Centre, who received his trial dose yesterday.
The trial site was UCLH Clinical Research Facility using space at the Royal London Hospital for Integrated Medicine (previously London Homeopathic Hospital) on Great Ormond Street.
The study doctor is Dr Carlos Estevez Fraga, from Madrid in Spain, who normally works in neurology on Huntingdon's Disease.
He volunteered for COVID-19 work and has recently been helping with the UK effort for the Oxford Vaccine Study
David Collier, clinical director at the William Harvey Clinical Research Centre, is featured by the London International Development Centre. His work in training staff research volunteers for rapidly developed COVID-19 studies is described here.
4 June 2020
His death will not be in vain…
Read the story of the first blood sample collected at Barts Health for the GenOMICC study.
Daily Telegraph, 21 May 2020
Followed up in The Guardian, 23/5/20 HERE
21/23 May 2020
These new videos describe COVID-19 research to patients and relatives. They were produced by patient John Greenwood's company, Greenacre, for Barts Health NHS Trust and are available in several languages.The project was organised by Dr Manish Saxena of the William Harvey Clinical Research Centre working with Neeta Patel, Barts Health NHS Trust.
Researchers within Barts Health Trust have launched a major effort to coördinate contributions to studies on the novel coronavirus and COVID-19 in hospitals in the trust including the Nightingale field hospital at the Excel conference centre. There is a link to a Telegraph news items describing this activity below.
“…Over the last two weeks, a new generation of code breakers has been assembling not at Bletchley Park but at Charterhouse Square, a secluded tree-lined pentagonal enclave in central London. This is the campus for Barts and the London School of Medicine and Dentistry, part of Queen Mary University of London, and here the task being undertaken is just as critical as Turing’s was nearly 80 years ago; part of a national effort to help save the country from an assault that, once again, is threatening our very way of life…”
18 April 2020
Professor Chloe Orkin, Lead for COVID -19 studies for Barts Health, tells us,
"An effective vaccine is what we all need. Great strides are being made on this and we want to make sure our staff and the population of East London are part of this. Barts Health has been leading the way on research and understanding of the disease. There are over 3000 people who have entered COVID -19 studies so far — a reflection of the willingness and desire to contribute.”
For a copy of our mailing with more details and the opportunity to participate in COVID-19 vaccine studies click HERE
15 July 2020
The RECOVERY trial included drugs that were relatively easy to get hold of, but some doctors just didn't think would help with COVID-19... It has now given us two hugely important answers:
1) Hydroxychloroquine does not help and, now
2) Dexamethasone is effective.
More RECOVERY details HERE
Click picture for Guardian news article
16 June 2020
It is no surprise to clinical trials patients that Dr David Collier, clinical director at the William Harvey Clinical Research Centre, has been busy…! The BBC World Service programme The Evidence, presented by Claudia Hammond, first broadcast 13 June includes a number of responses by a panel of experts to listeners questions. The panel included… David Collier.
That second part continues after the news at about 26min 30secs.
14 June 2020
Training for the volunteer staff helping with this research is taking place at the William Harvey Clinical Research Centre, Charterhouse Square, where TrialsConnect is based.
Patients have been consulted on rapidly produced information and consent materials as well as having a representative on the coördinating group.
8 April 2020